A Transcontinental African Railroad could be the transformative infrastructure Africa has long awaited. For centuries, global ...

MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for ...

In the rapidly evolving field of pharmaceuticals, China's role as a hub for innovative drug development continues to expand, particularly in its outbound strategies. As we approach the end of 2025, ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Explore eight major immunology and inflammation (I&I) partnerships in 2025, from early-stage research to late-stage licensing ...

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive ...

Pfizer, which makes the shot, is fighting a lawsuit from more than 1,000 women who claim the company knew about the risk of meningiomas but failed to warn patients. Meanwhile, former Vice President ...

Ascentage Pharma's first approved product, Olverembatinib, is the first novel third-generation BCR-ABL1 inhibitor approved in ...

Merck, Pfizer and Astellas, which in August reported similar results from a Phase 3 study of the combination in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based ...

Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 Revenue guidance(2) and ...